Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
59.63
+0.89 (1.52%)
At close: Oct 3, 2025, 4:00 PM EDT
59.80
+0.17 (0.29%)
After-hours: Oct 3, 2025, 7:59 PM EDT
Novo Nordisk Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$85.25
Upside
+42.96%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold → Sell Downgrades $59 → $47 | Hold → Sell | Downgrades | $59 → $47 | -21.18% | Sep 29, 2025 |
| Berenberg | Berenberg | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 17, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $105 → $70 | Strong Buy | Maintains | $105 → $70 | +17.39% | Aug 19, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 5, 2025 |
| HSBC | HSBC | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 31, 2025 |
| Barclays | Barclays | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 30, 2025 |
| TD Cowen | TD Cowen | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +76.09% | Jun 18, 2025 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $105 → $64 | Buy → Hold | Downgrades | $105 → $64 | +7.33% | Apr 17, 2025 |
| UBS | UBS | Strong Sell → Strong Buy Upgrades n/a | Strong Sell → Strong Buy | Upgrades | n/a | n/a | Jan 8, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $156 → $105 | Buy | Maintains | $156 → $105 | +76.09% | Dec 23, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $155 → $105 | Strong Buy | Maintains | $155 → $105 | +76.09% | Dec 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +168.32% | Nov 6, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $160 → $156 | Buy | Maintains | $160 → $156 | +161.61% | Oct 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +168.32% | Oct 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +168.32% | Sep 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +168.32% | Sep 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.